ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 407 out of 2094

$439K Total Retail Price of All Prescriptions

Rank: 601 out of 2094

246 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 246 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 300 262 1 2
FUROSEMIDE 263 234 2 6
WARFARIN SODIUM 262 261 3 11
LEVOTHYROXINE SODIUM 244 219 4 3
OMEPRAZOLE 155 146 5 4
POTASSIUM CHLORIDE 136 130 6 24
FAMOTIDINE 136 121 6 34
GABAPENTIN 132 99 8 23
METOPROLOL TARTRATE 123 114 9 10
SIMVASTATIN 116 113 10 1
DONEPEZIL HCL 108 108 11 20
LEVETIRACETAM 99 81 12 78
OXYCODONE-ACETAMINOPHEN 97 84 S2 13 40
METOPROLOL SUCCINATE 93 89 14 9
LANTUS 91 77 15 66
IPRATROPIUM-ALBUTEROL 87 69 16 92
QUETIAPINE FUMARATE 85 65 17 71
NOVOLOG 84 67 18 116
SERTRALINE HCL 82 69 19 26
NAMENDA 78 78 20 32
OXYCONTIN 76 46 S2 21 98
CLONIDINE HCL 75 73 22 62
LISINOPRIL 71 63 23 7
MIRTAZAPINE 69 66 24 43
TAMSULOSIN HCL 65 64 25 29
CYMBALTA 64 54 26 61
PREDNISONE 61 47 27 54
DIGOXIN 61 56 27 51
ENALAPRIL MALEATE 57 32 29 25
HUMALOG 56 56 30 164
CARVEDILOL 54 53 31 19
ATENOLOL 51 50 32 21
CLOPIDOGREL 50 38 33 22
OLANZAPINE 50 41 33 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.